Your session is about to expire
← Back to Search
Behavioral Intervention
Addressing Violence and HIV Care Among Transgender Women
N/A
Waitlist Available
Led By Kristi Gamarel, PhD
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3-month follow up
Awards & highlights
No Placebo-Only Group
Summary
This trial tests a program called 'Kickin' it with the Gurlz' designed for transgender women of color who have experienced trauma. The program includes tools to address violence and gender issues, supportive group activities, and personal assistance to improve HIV care.
Eligible Conditions
- Human Immunodeficiency Virus (HIV) Infection
- HIV Suppression
- Acceptability of Health Care
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3-month follow up
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3-month follow up
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Acceptability Quantitative
Secondary study objectives
Acceptability Qualitative
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Kicking it with the GurlzExperimental Treatment1 Intervention
This multicomponent intervention includes a violence and gender affirmation screening tool, a peer delivered adaptation of the group-level Seeking Safety Program, and individual-level peer navigation sessions.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Kickin it with the Gurlz
2021
N/A
~20
Find a Location
Who is running the clinical trial?
University of MichiganLead Sponsor
1,860 Previous Clinical Trials
6,437,909 Total Patients Enrolled
Kristi Gamarel, PhDPrincipal Investigator - University of Michigan
University of Michigan
3 Previous Clinical Trials
385 Total Patients Enrolled